I. Paul Bae

I. Paul Bae

59 year
Health Technology
Consumer Services

Profile

I.
Paul Bae worked as Litigation Director at Alpha Therapeutic Corp., Vice President-Human Resources at Aerie Pharmaceuticals, Inc., and VP-Global Human Resources at St. Jude Medical LLC.
He completed his undergraduate degree at the University of California, Los Angeles and his graduate degree at Mcgeorge School of Law.

Former positions of I. Paul Bae

CompaniesPositionEnd
Alpha Therapeutic Corp.
Logo Alpha Therapeutic Corp.

Alpha Therapeutic Corp.

BiotechnologyHealth Technology

Part of Grifols SA/Grifols Family/, Alpha Therapeutic Corp. develops plasma derived products. The company is based in Los Angeles, CA.

 General Counsel -
AERIE PHARMACEUTICALS, INC. Human Resources Officer -
ST JUDE MEDICAL INC Chief Administrative Officer -
See the detail of I. Paul Bae's experience

Training of I. Paul Bae

University of California, Los Angeles Undergraduate Degree
Mcgeorge School of Law Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of I. Paul Bae's experience

Linked companies

Private companies3
St. Jude Medical LLC
Logo St. Jude Medical LLC

St. Jude Medical LLC

Medical SpecialtiesHealth Technology

St. Jude Medical LLC develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The company was founded by Manuel A. Villafana in 1976 and is headquartered in St. Paul, MN.

Health Technology

Alpha Therapeutic Corp.
Logo Alpha Therapeutic Corp.

Alpha Therapeutic Corp.

BiotechnologyHealth Technology

Part of Grifols SA/Grifols Family/, Alpha Therapeutic Corp. develops plasma derived products. The company is based in Los Angeles, CA.

Health Technology

Aerie Pharmaceuticals, Inc.
Logo Aerie Pharmaceuticals, Inc.

Aerie Pharmaceuticals, Inc.

Pharmaceuticals: MajorHealth Technology

Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX.

Health Technology

  1. Stock Market
  2. Insiders
  3. I. Paul Bae